Company: LIMN
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001104659-25-055078
Chunk: 30

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 30
---
.7 and are incorporated
herein by reference.

(b) Pro Forma Financial Information.

Certain unaudited pro forma
condensed combined financial information is filed herewith as Exhibit 99.3 and is incorporated herein by reference.

(d) Exhibits.

The following exhibits are
filed as part of, or incorporated by reference into, this Report.

<div align='center'>19</div>

| Exhibit 
 No.     
 2.1     
 2.2*    |     | Description                                                                                                                                                                                                                                                                                                                                  
 Business Combination Agreement, dated November 30, 2022, as amended, by and among Iris Acquisition Corp, Iris Parent Holding Corp., Liminatus Pharma, LLC, Liminatus Pharma Merger Sub, Inc. and SPAC Merger Sub, Inc. (incorporated by reference to Annex A to the proxy statement/prospectus filed with the SEC on February 7, 2025).      
 Certificate of Merger of Liminatus Pharma, LLC and Liminatus Pharma Merger Sub, Inc. filed on April 30, 2025.                                                                                                                                                                                                                                |
|:--------|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.3*    |     | Certificate of Merger of Iris Acquisition Corp and SPAC Merger Sub, Inc. filed on April 30, 2025.                                                                                                                                                                                                                                            |
| 3.1*    |     | Amended and Restated                                                                                                                                                                                                                                                                                                                         
 Certificate of Incorporation of Iris Parent Holding Corp. (renamed Liminatus Pharma, Inc.) filed on April 30, 2025.                                                                                                                                                                                                                          |
| 3.2     |     | Amended and Restated Bylaws of Iris Parent Holding Corp. (renamed Liminatus Pharma, Inc.) (incorporated by reference to Annex I to the proxy statement/prospectus filed with the SEC on February 7, 2025).                                                                                                                                   |
| 4.1     |     | Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registration Statement on Form S-4 (File No. 333-275409), filed by the Registrant with the SEC on November 8, 2023).                                                                                                                                      |
| 4.2     |     | Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 of the Registration Statement on Form S-1 (File No. 333-252413), filed by Iris